|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4704 | |
| A61P 25/00 | |||
| A61P 25/16 | |||
| A61P 25/18 | |||
| A61P 25/22 | |||
| A61P 25/24 | |||
| A61P 25/28 | |||
| A61K 31/138 | |||
| A61K 31/428 |
| (11) | Number of the document | 3064206 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16160522.5 |
| Date of filing the European patent application | 2010-08-09 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 273920 P | 2009-08-10 | US |
| (72) |
HAYARDENY, Liat, IL
|
| (73) |
Active Biotech AB,
Box 724, 220 07 Lund,
SE
|
| (54) | TREATMENT OF HUNTINGTON`S DISEASE USING LAQUINIMOD |
| TREATMENT OF HUNTINGTON`S DISEASE USING LAQUINIMOD |